abstract |
A novel stable preparation of recombinant protein medicine belongs to the field of pharmaceutical preparation research. The protein pharmaceutical preparation provided by the present invention includes the active ingredient recombinant fusion protein, phosphate buffer system, trehalose, amino acid and sodium caprylate. The pharmaceutical preparation of the present invention is suitable for subcutaneous or intravenous administration, and neutropenia can be treated by injecting a suitable dose of the pharmaceutical preparation. |